Cargando…
The Role of the Level of Interleukin-33 in the Therapeutic Outcomes of Immunotherapy in Patients with Allergic Rhinitis
Introduction Allergic rhinitis (AR) affects up to 40% of the population and results in nasal itching, congestion, sneezing, and clear rhinorrhea. Objectives This study aimed to evaluate the changes in the clinical symptoms and in the level of serum interleukin (IL)-33 before and after pollen immun...
Autores principales: | Nasr, Wail Fayez, Sorour, Samir Sorour, El Bahrawy, Atef Taha, Boghdadi, Ghada Samir, El Shahaway, Alia A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Revinter Publicações Ltda
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882380/ https://www.ncbi.nlm.nih.gov/pubmed/29619104 http://dx.doi.org/10.1055/s-0037-1605596 |
Ejemplares similares
-
Platelet-Rich Plasma in Reconstruction of Posterior Meatal Wall after Canal Wall Down Mastoidectomy
por: Elbary, Mohammad El-Sayed Abd, et al.
Publicado: (2017) -
Adipose Tissue-Derived Mesenchymal Stem Cell Modulates the Immune Response of Allergic Rhinitis in a Rat Model
por: Ebrahim, Nesrine, et al.
Publicado: (2019) -
The Role of Interleukin-33 in Rhinitis
por: Rogala, Barbara, et al.
Publicado: (2013) -
Serum levels of interleukin 33 and its receptor ST2 in patients treated with subcutaneous allergen immunotherapy in intermittent allergic rhinitis
por: Glück, Joanna, et al.
Publicado: (2019) -
Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011)